Absci Corporation (ABSI) vs Agios Pharmaceuticals, Inc. (AGIO)

A side-by-side comparison of Absci Corporation and Agios Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ABSI vs AGIO

growth of $100 · dividends reinvested · last 5y
ABSI -46.6% (-11.8%/yr)AGIO -43.7% (-10.8%/yr)AGIO compounded faster over this window
050100150Start $10020222023202420252026$53$56
ABSI AGIO

ABSI vs AGIO: by the numbers

  • •ABSI is the larger company ($1.99B vs $1.88B market cap).
  • •Both run net losses; AGIO's is the smaller (-418.24% vs -7756.37% net margin).
  • •AGIO grew revenue faster over the past five years (4.54% vs -22.08% CAGR).

Metrics side by side

Valuation

MetricABSIAGIO
P/S ratio1277.2819.12
P/B ratio8.101.83

Profitability

MetricABSIAGIO
Gross margin-319.36%78.67%
Operating margin-4454.21%-873.87%
Net margin-7756.37%-418.24%
ROE-49.19%-40.09%
ROIC-52.66%-44.21%

Growth (annualized)

MetricABSIAGIO
Revenue CAGR (5Y)-22.08%4.54%
Total return CAGR (5Y)0.89%-6.59%

Frequently asked

Which has grown faster, ABSI or AGIO?
Over the past five years, AGIO grew revenue faster — ABSI at a -22.08% CAGR versus AGIO at 4.54%.
How have ABSI and AGIO total returns compared?
Over the past 5 years, ABSI delivered 0.89% and AGIO delivered -6.59% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.